These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25034455)

  • 1. Is abnormal non-high-density lipoprotein cholesterol a gender-specific predictor for metabolic syndrome in patients with schizophrenia taking second-generation antipsychotics?
    Lin EC; Shao WC; Yang HJ; Yen M; Lee SY; Wu PC; Lu RB
    Metab Brain Dis; 2015 Feb; 30(1):107-13. PubMed ID: 25034455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between serum adiponectin levels, cardiometabolic indices and metabolic syndrome in schizophrenia.
    Tay YH; Lee J
    Asian J Psychiatr; 2019 Jun; 43():1-6. PubMed ID: 31059867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia.
    Sagud M; Vlatkovic S; Svob Strac D; Sviben M; Zivkovic M; Vilibic M; Vuksan-Cusa B; Mihaljevic-Peles A; Pivac N
    Compr Psychiatry; 2018 Apr; 82():115-120. PubMed ID: 29477703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
    Rawat VS; Ganesh S; Bijjal S; Shanivaram Reddy K; Agarwal V; Devi R; Kumar CN; Christopher R; Thirthalli J
    Schizophr Res; 2018 Feb; 192():102-107. PubMed ID: 28454923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing Prevalence and Correlates of Metabolic Syndromes Between Chlorpromazine and Clozapine: A 10-year Retrospective Study of a Male Chinese Cohort.
    Xing M; Sheng J; Cui M; Su Y; Zhang C; Chen X; Fang Y; Cui D; Li Z
    Curr Neuropharmacol; 2022; 20(10):1969-1977. PubMed ID: 35236263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype.
    Zhang Y; Chen M; Chen J; Wu Z; Yu S; Fang Y; Zhang C
    Psychopharmacology (Berl); 2014 May; 231(10):2211-8. PubMed ID: 24448899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome among psychiatric inpatients with schizophrenia in Indonesia.
    Marthoenis M; Aichberger MC; Puteh I; Syahrial S; Schouler-Ocak M
    Asian J Psychiatr; 2015 Jun; 15():10-4. PubMed ID: 25910596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care.
    Seow LS; Chong SA; Wang P; Shafie S; Ong HL; Subramaniam M
    Compr Psychiatry; 2017 Apr; 74():196-203. PubMed ID: 28214752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between smoking, components of metabolic syndrome and lipoprotein particle size.
    Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH
    BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid monitoring in patients with schizophrenia prescribed second-generation antipsychotics.
    Weissman EM; Zhu CW; Schooler NR; Goetz RR; Essock SM
    J Clin Psychiatry; 2006 Sep; 67(9):1323-6. PubMed ID: 17017817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of metabolic syndrome and its prediction in Japanese inpatients with schizophrenia.
    Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
    Hum Psychopharmacol; 2013 Mar; 28(2):188-91. PubMed ID: 23475497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and gender-specific distribution of metabolic syndrome components in East China: role of hypertriglyceridemia in the SPECT-China study.
    Jiang B; Zheng Y; Chen Y; Chen Y; Li Q; Zhu C; Wang N; Han B; Zhai H; Lin D; Lu Y
    Lipids Health Dis; 2018 Apr; 17(1):92. PubMed ID: 29678174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
    Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
    Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best anthropometric and atherogenic predictors of metabolic syndrome in the Chinese Han population in Xinjiang: the Cardiovascular Risk Survey.
    Chen BD; He CH; Ma YT; Yang YN; Liu F; Pan S; Ma X; Li XM; Fu ZY; Xie X; Zheng YY
    Ann Nutr Metab; 2014; 65(4):280-8. PubMed ID: 25376983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
    Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
    Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal associations of high-density lipoprotein cholesterol or low-density lipoprotein cholesterol with metabolic syndrome in the Chinese population: a prospective cohort study.
    Wang XR; Song GR; Li M; Sun HG; Fan YJ; Liu Y; Liu QG
    BMJ Open; 2018 May; 8(5):e018659. PubMed ID: 29743317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
    Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors for metabolic syndrome in schizophrenia, schizoaffective, and bipolar disorder.
    Mohd Ahmed H; Abdel Aziz K; Al Ammari A; Galadari M; Alsaadi A; Alhassani A; Al Marzooqi F; AlAhbabi M; Alsheryani H; Bahayan M; Ahmed R; Alameri S; Stip E; Aly El-Gabry D
    Int J Psychiatry Clin Pract; 2024 Mar; 28(1):35-44. PubMed ID: 38329470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.